-
1
-
-
84860287080
-
Epidemiology of viral hepatitis and hepatocellular carcinoma
-
El-Serag HB: Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264.e1-1273.e1
-
(2012)
Gastroenterology
, vol.142
-
-
El-Serag, H.B.1
-
3
-
-
0032879468
-
Prognosis of hepatocellular carcinoma: The BCLC staging classification
-
Llovet JM, Bru C, Bruix J: Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329-338
-
(1999)
Semin Liver Dis
, vol.19
, pp. 329-338
-
-
Llovet, J.M.1
Bru, C.2
Bruix, J.3
-
4
-
-
0031782818
-
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators
-
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998; 28: 751-755
-
(1998)
Hepatology
, vol.28
, pp. 751-755
-
-
-
5
-
-
10644225254
-
Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score
-
Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T: Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score. Hepatology 2004; 40: 1396-1405
-
(2004)
Hepatology
, vol.40
, pp. 1396-1405
-
-
Kudo, M.1
Chung, H.2
Haji, S.3
Osaki, Y.4
Oka, H.5
Seki, T.6
Kasugai, H.7
Sasaki, Y.8
Matsunaga, T.9
-
6
-
-
20044364922
-
Proposal of a new prognostic model for hepatocellular carcinoma: An analysis of 403 patients
-
Tateishi R, Yoshida H, Shiina S, Imamura H, Hasegawa K, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Makuuchi M, Omata M: Proposal of a new prognostic model for hepatocellular carcinoma: An analysis of 403 patients. Gut 2005; 54: 419-425
-
(2005)
Gut
, vol.54
, pp. 419-425
-
-
Tateishi, R.1
Yoshida, H.2
Shiina, S.3
Imamura, H.4
Hasegawa, K.5
Teratani, T.6
Obi, S.7
Sato, S.8
Koike, Y.9
Fujishima, T.10
Makuuchi, M.11
Omata, M.12
-
7
-
-
84858658381
-
European organisation for research and treatment of cancer: Easl-eortc clinical practice guidelines: Management of hepatocellular carcinoma
-
European Association for the Study of the Liver
-
European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943
-
(2012)
J Hepatol
, vol.56
, pp. 908-943
-
-
-
8
-
-
16244369103
-
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort
-
Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS: Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort. Hepatology 2005; 41: 707-716
-
(2005)
Hepatology
, vol.41
, pp. 707-716
-
-
Marrero, J.A.1
Fontana, R.J.2
Barrat, A.3
Askari, F.4
Conjeevaram, H.S.5
Su, G.L.6
Lok, A.S.7
-
9
-
-
33644909117
-
Prospective validation of the Barcelona Clinic Liver Cancer staging system
-
Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, Neri D, Boccagni P, Srsen N, D'Amico F, Ciarleglio FA, Bridda A, D'Amico DF: Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 2006; 44: 723-731
-
(2006)
J Hepatol
, vol.44
, pp. 723-731
-
-
Cillo, U.1
Vitale, A.2
Grigoletto, F.3
Farinati, F.4
Brolese, A.5
Zanus, G.6
Neri, D.7
Boccagni, P.8
Srsen, N.9
D'Amico, F.10
Ciarleglio, F.A.11
Bridda, A.12
D'Amico, D.F.13
-
10
-
-
40949127006
-
Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response
-
Guglielmi A, Ruzzenente A, Pachera S, Valdegamberi A, Sandri M, D'Onofrio M, Iacono C: Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response. Am J Gastroenterol 2008; 103: 597-604
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 597-604
-
-
Guglielmi, A.1
Ruzzenente, A.2
Pachera, S.3
Valdegamberi, A.4
Sandri, M.5
D'Onofrio, M.6
Iacono, C.7
-
11
-
-
84863522066
-
Kim do Y, Ahn SH, Park MS, Kim EH, Seong J, Lee do Y, Han KH: Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: Single centre experience from long-term clinical outcomes of 1,717 treatment- naive patients with hepatocellular carcinoma
-
Kim BK, Kim SU, Park JY, Kim do Y, Ahn SH, Park MS, Kim EH, Seong J, Lee do Y, Han KH: Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: Single centre experience from long-term clinical outcomes of 1,717 treatment- naive patients with hepatocellular carcinoma. Liver Int 2012; 32: 1120-1127
-
(2012)
Liver Int
, vol.32
, pp. 1120-1127
-
-
Kim, B.K.1
Kim, S.U.2
Park, J.Y.3
-
12
-
-
77954016931
-
Selecting an optimal staging system for hepatocellular carcinoma: Comparison of 5 currently used prognostic models
-
Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Lee PC, Loong CC, Chiang JH, Huo TI, Lee SD: Selecting an optimal staging system for hepatocellular carcinoma: Comparison of 5 currently used prognostic models. Cancer 2010; 116: 3006-3014
-
(2010)
Cancer
, vol.116
, pp. 3006-3014
-
-
Hsu, C.Y.1
Hsia, C.Y.2
Huang, Y.H.3
Su, C.W.4
Lin, H.C.5
Lee, P.C.6
Loong, C.C.7
Chiang, J.H.8
Huo, T.I.9
Lee, S.D.10
-
13
-
-
84869080379
-
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
-
Shao YY, Lu LC, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL: Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems. Br J Cancer 2012; 107: 1672-1677
-
(2012)
Br J Cancer
, vol.107
, pp. 1672-1677
-
-
Shao, Y.Y.1
Lu, L.C.2
Lin, Z.Z.3
Hsu, C.4
Shen, Y.C.5
Hsu, C.H.6
Cheng, A.L.7
-
14
-
-
84867147874
-
Prognosis of patients with hepatocellular carcinoma validation and ranking of established staging-systems in a large western hcc-cohort
-
Op Den Winkel M, Nagel D, Sappl J, op Den Winkel P, Lamerz R, Zech CJ, Straub G, Nickel T, Rentsch M, Stieber P, Goke B, Kolligs FT: Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort. PLoS One 2012; 7:e45066
-
(2012)
PLoS One
, Issue.7
-
-
Op Den Winkel, M.1
Nagel, D.2
Sappl, J.3
Op Den Winkel, P.4
Lamerz, R.5
Zech, C.J.6
Straub, G.7
Nickel, T.8
Rentsch, M.9
Stieber, P.10
Goke, B.11
Kolligs, F.T.12
-
15
-
-
20244367468
-
The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma
-
Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K, Yamaoka T, Iwatani Y, Akazawa K, Takenaka K: The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005; 103: 1856-1864
-
(2005)
Cancer
, vol.103
, pp. 1856-1864
-
-
Hashimoto, K.1
Ikeda, Y.2
Korenaga, D.3
Tanoue, K.4
Hamatake, M.5
Kawasaki, K.6
Yamaoka, T.7
Iwatani, Y.8
Akazawa, K.9
Takenaka, K.10
-
16
-
-
84867987446
-
Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma
-
Kinoshita A, Onoda H, Takano K, Imai N, Saeki C, Fushiya N, Miyakawa Y, Nishino H, Tajiri H: Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma. Med Oncol 2012; 29: 2800-2808
-
(2012)
Med Oncol
, vol.29
, pp. 2800-2808
-
-
Kinoshita, A.1
Onoda, H.2
Takano, K.3
Imai, N.4
Saeki, C.5
Fushiya, N.6
Miyakawa, Y.7
Nishino, H.8
Tajiri, H.9
-
17
-
-
84879075398
-
Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma
-
Sieghart W, Pinter M, Hucke F, Graziadei I, Schoniger-Hekele M, Muller C, Vogel W, Trauner M, Peck-Radosavljevic M: Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma. Hepatology 2013; 57: 2224-2234
-
(2013)
Hepatology
, vol.57
, pp. 2224-2234
-
-
Sieghart, W.1
Pinter, M.2
Hucke, F.3
Graziadei, I.4
Schoniger-Hekele, M.5
Muller, C.6
Vogel, W.7
Trauner, M.8
Peck-Radosavljevic, M.9
-
18
-
-
84873044617
-
The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
-
Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H, Matsushima M, Saeki C, Tajiri H: The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma. BMC Cancer 2013; 13: 52
-
(2013)
BMC Cancer
, Issue.13
, pp. 52
-
-
Kinoshita, A.1
Onoda, H.2
Imai, N.3
Iwaku, A.4
Oishi, M.5
Tanaka, K.6
Fushiya, N.7
Koike, K.8
Nishino, H.9
Matsushima, M.10
Saeki, C.11
Tajiri, H.12
-
19
-
-
34249322375
-
Staging of hepatocellular carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan
-
Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M: Staging of hepatocellular carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 2007; 245: 909-922
-
(2007)
Ann Surg
, vol.245
, pp. 909-922
-
-
Minagawa, M.1
Ikai, I.2
Matsuyama, Y.3
Yamaoka, Y.4
Makuuchi, M.5
-
20
-
-
0015370847
-
Clinical biostatisticsx XVI The process of prognostic stratification
-
Feinsten AR: Clinical biostatisticsx. XVI. The process of prognostic stratification. Clin Pharmacol Ther 1972; 13: 609-624
-
(1972)
Clin Pharmacol Ther
, vol.13
, pp. 609-624
-
-
Feinsten, A.R.1
-
21
-
-
0034861620
-
Discrimination value of the new western prognostic system (clip score) for hepatocellular carcinoma in 662 japanese patients cancer of the liver italian program
-
Ueno S, Tanabe G, Sako K, Hiwaki T, Hokotate H, Fukukura Y, Baba Y, Imamura Y, Aikou T: Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001; 34: 529-534
-
(2001)
Hepatology
, vol.34
, pp. 529-534
-
-
Ueno, S.1
Tanabe, G.2
Sako, K.3
Hiwaki, T.4
Hokotate, H.5
Fukukura, Y.6
Baba, Y.7
Imamura, Y.8
Aikou, T.9
-
22
-
-
75149189004
-
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
-
Roxburgh CS, McMillan DC: Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6: 149-163
-
(2010)
Future Oncol
, vol.6
, pp. 149-163
-
-
Roxburgh, C.S.1
McMillan, D.C.2
-
24
-
-
34250873779
-
A systematic review of the association between circulating concentrations of C reactive protein and cancer
-
Heikkila K, Ebrahim S, Lawlor DA: A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 2007; 61: 824-833
-
(2007)
J Epidemiol Community Health
, vol.61
, pp. 824-833
-
-
Heikkila, K.1
Ebrahim, S.2
Lawlor, D.A.3
-
25
-
-
0026691627
-
Serum levels of cytokines in chronic liver diseases
-
Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C: Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-274
-
(1992)
Gastroenterology
, vol.103
, pp. 264-274
-
-
Tilg, H.1
Wilmer, A.2
Vogel, W.3
Herold, M.4
Nolchen, B.5
Judmaier, G.6
Huber, C.7
-
26
-
-
48649109203
-
Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis
-
Sakurai T, He G, Matsuzawa A, Yu GY, Maeda S, Hardiman G, Karin M: Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 2008; 14: 156-165
-
(2008)
Cancer Cell
, vol.14
, pp. 156-165
-
-
Sakurai, T.1
He, G.2
Matsuzawa, A.3
Yu, G.Y.4
Maeda, S.5
Hardiman, G.6
Karin, M.7
-
27
-
-
73149100826
-
Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin- 6 expression
-
Maeda S, Hikiba Y, Sakamoto K, Nakagawa H, Hirata Y, Hayakawa Y, Yanai A, Ogura K, Karin M, Omata M: Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin- 6 expression. Hepatology 2009; 50: 1851-1860
-
(2009)
Hepatology
, vol.50
, pp. 1851-1860
-
-
Maeda, S.1
Hikiba, Y.2
Sakamoto, K.3
Nakagawa, H.4
Hirata, Y.5
Hayakawa, Y.6
Yanai, A.7
Ogura, K.8
Karin, M.9
Omata, M.10
-
28
-
-
74549167737
-
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression
-
Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M: Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010; 140: 197-208
-
(2010)
Cell
, Issue.140
, pp. 197-208
-
-
Park, E.J.1
Lee, J.H.2
Yu, G.Y.3
He, G.4
Ali, S.R.5
Holzer, R.G.6
Osterreicher, C.H.7
Takahashi, H.8
Karin, M.9
-
29
-
-
65649111667
-
High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B
-
Wong VW, Yu J, Cheng AS, Wong GL, Chan HY, Chu ES, Ng EK, Chan FK, Sung JJ, Chan HL: High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer 2009; 124: 2766-2770
-
(2009)
Int J Cancer
, vol.124
, pp. 2766-2770
-
-
Wong, V.W.1
Yu, J.2
Cheng, A.S.3
Wong, G.L.4
Chan, H.Y.5
Chu, E.S.6
Ng, E.K.7
Chan, F.K.8
Sung, J.J.9
Chan, H.L.10
-
30
-
-
70349849505
-
Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: An analysis based on gender differences
-
Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, Hayakawa Y, Kinoshita H, Yamakado M, Kato N, Shiina S, Omata M: Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: An analysis based on gender differences. Int J Cancer 2009; 125: 2264-2269
-
(2009)
Int J Cancer
, vol.125
, pp. 2264-2269
-
-
Nakagawa, H.1
Maeda, S.2
Yoshida, H.3
Tateishi, R.4
Masuzaki, R.5
Ohki, T.6
Hayakawa, Y.7
Kinoshita, H.8
Yamakado, M.9
Kato, N.10
Shiina, S.11
Omata, M.12
-
31
-
-
83555163795
-
Impact of an inflammation- based prognostic system on patients undergoing surgery for hepatocellular carcinoma: A retrospective study of 398 Japanese patients
-
Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T: Impact of an inflammation- based prognostic system on patients undergoing surgery for hepatocellular carcinoma: A retrospective study of 398 Japanese patients. Am J Surg 2012; 203: 101-106
-
(2012)
Am J Surg
, vol.203
, pp. 101-106
-
-
Ishizuka, M.1
Kubota, K.2
Kita, J.3
Shimoda, M.4
Kato, M.5
Sawada, T.6
-
32
-
-
84863176533
-
Inflammation-based prognostic score for hepatocellular carcinoma patients on sorafenib treatment
-
Morimoto M, Numata K, Moriya S, Kondo M, Nozaki A, Morioka Y, Maeda S, Tanaka K: Inflammation-based prognostic score for hepatocellular carcinoma patients on sorafenib treatment. Anticancer Res 2012; 32: 619-623
-
(2012)
Anticancer Res
, vol.32
, pp. 619-623
-
-
Morimoto, M.1
Numata, K.2
Moriya, S.3
Kondo, M.4
Nozaki, A.5
Morioka, Y.6
Maeda, S.7
Tanaka, K.8
-
33
-
-
80755128486
-
A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study
-
Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS, Foulis AK, Horgan PG, McMillan DC: A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer 2011; 47: 2633-2641
-
(2011)
Eur J Cancer
, Issue.47
, pp. 2633-2641
-
-
Proctor, M.J.1
Morrison, D.S.2
Talwar, D.3
Balmer, S.M.4
Fletcher, C.D.5
O'Reilly, D.S.6
Foulis, A.K.7
Horgan, P.G.8
McMillan, D.C.9
-
34
-
-
84865865572
-
Comparison of the prognostic value of inflammation- based prognostic scores in patients with hepatocellular carcinoma
-
Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Fushiya N, Koike K, Nishino H, Tajiri H: Comparison of the prognostic value of inflammation- based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 2012; 107: 988-993
-
(2012)
Br J Cancer
, vol.107
, pp. 988-993
-
-
Kinoshita, A.1
Onoda, H.2
Imai, N.3
Iwaku, A.4
Oishi, M.5
Fushiya, N.6
Koike, K.7
Nishino, H.8
Tajiri, H.9
-
35
-
-
84872153048
-
Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system
-
Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Lee FY, Huo TI: Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology 2013; 57: 112-119
-
(2013)
Hepatology
, vol.57
, pp. 112-119
-
-
Hsu, C.Y.1
Lee, Y.H.2
Hsia, C.Y.3
Huang, Y.H.4
Su, C.W.5
Lin, H.C.6
Lee, R.C.7
Chiou, Y.Y.8
Lee, F.Y.9
Huo, T.I.10
-
36
-
-
84874112331
-
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma
-
Diouf M, Filleron T, Barbare JC, Fin L, Picard C, Bouche O, Dahan L, Paoletti X, Bonnetain F: The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma. J Hepatol 2013; 58: 509-521
-
(2013)
J Hepatol
, vol.58
, pp. 509-521
-
-
Diouf, M.1
Filleron, T.2
Barbare, J.C.3
Fin, L.4
Picard, C.5
Bouche, O.6
Dahan, L.7
Paoletti, X.8
Bonnetain, F.9
-
37
-
-
84876986843
-
The systemic inflammationbased Glasgow Prognostic Score: A decade of experience in patients with cancer
-
McMillan DC: The systemic inflammationbased Glasgow Prognostic Score: A decade of experience in patients with cancer. Cancer Treat Rev 2013; 39: 534-540.
-
(2013)
Cancer Treat Rev
, vol.39
, pp. 534-540
-
-
McMillan, D.C.1
|